Heterogeneity of HSCs in a Mouse Model of NASH
- 10 August 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 74 (2) , 667-685
Abstract
Background and Aims: In clinical and experimental NASH, the origin of the scar‐forming myofibroblast is the HSC. We used foz/foz mice on a Western diet to characterize in detail the phenotypic changes of HSCs in a NASH model. Approach and Results: We examined the single‐cell expression profiles (scRNA sequencing) of HSCs purified from the normal livers of foz/foz mice on a chow diet, in NASH with fibrosis of foz/foz mice on a Western diet, and in livers during regression of NASH after switching back to a chow diet. Selected genes were analyzed using immunohistochemistry, quantitative real‐time PCR, and short hairpin RNA knockdown in primary mouse HSCs. Our analysis of the normal liver identified two distinct clusters of quiescent HSCs that correspond to their acinar position of either pericentral vein or periportal vein. The NASH livers had four distinct HSC clusters, including one representing the classic fibrogenic myofibroblast. The three other HSC clusters consisted of a proliferating cluster, an intermediate activated cluster, and an immune and inflammatory cluster. The livers with NASH regression had one cluster of inactivated HSCs, which was similar to, but distinct from, the quiescent HSCs. Conclusions: Analysis of single‐cell RNA sequencing in combination with an interrogation of previous studies revealed an unanticipated heterogeneity of HSC phenotypes under normal and injured states.Keywords
Funding Information
- National Institute of Environmental Health Sciences (P42 ES010337)
- National Institute on Alcohol Abuse and Alcoholism (P50 AA011999)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK063491, P30 DK120515, R01 DK091183, T32 DK007044)
This publication has 38 references indexed in Scilit:
- The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cellsNature Biotechnology, 2014
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiologyNature Communications, 2013
- Strain dependence of diet‐induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotypeLiver International, 2013
- Reversibility of Liver Fibrosis and Inactivation of Fibrogenic MyofibroblastsCurrent Pathobiology Reports, 2013
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosisProceedings of the National Academy of Sciences, 2012
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic SteatohepatitisGastroenterology, 2011
- Migration of Fibrocytes in Fibrogenic Liver InjuryThe American Journal of Pathology, 2011
- Fat Aussie—A New Alström Syndrome Mouse Showing a Critical Role for ALMS1 in Obesity, Diabetes, and SpermatogenesisMolecular Endocrinology, 2006
- Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant miceBiochemical and Biophysical Research Communications, 2006
- Role of the Ets-1 Transcription Factor during Activation of Rat Hepatic Stellate Cells in CultureThe American Journal of Pathology, 1999